ReviewThe Journal of clinical investigation2019
Killers 2.0: NK cell therapies at the forefront of cancer control.
Jonathan J Hodgins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
150 papers cite itlatest 60 shown
this paperpooled ittrialcites it